Peter Harper
- Oncology top 0.5%
- Lung Cancer Research Studies 28
- Colorectal Cancer Treatments and Studies 15
- Cancer Treatment and Pharmacology 14
- Pulmonary and Respiratory Medicine top 0.5%
- Lung Cancer Treatments and Mutations 25
- Gastric Cancer Management and Outcomes 17
- Lung Cancer Diagnosis and Treatment 12
- Gastroenterology top 1%
- Reproductive Medicine top 1%
- Cancer Research top 2%
-
- Neuroendocrine Tumor Research Advances 18
-
- Esophageal Cancer Research and Treatment 14
- Co-authors
- David CunninghamAllan B. OkeyDavid S. RiddickTamas HickishA. NormanTimothy IvesonStephen SpiroJuan W. Valle
- Journals
- Journal of Clinical Oncology (16 papers)Cancer Chemotherapy and Pharmacology (15 papers)Annals of Oncology (11 papers)
- Partner nations
- United KingdomUnited StatesCanada
In The Last Decade
Peter Harper
136 papers receiving 7.5k citations
Hit Papers
Peers
Comparison fields: 5 of 130
- Oncology 4.7k
- Pulmonary and Respiratory Medicine 3.2k
- Gastroenterology 421
- Reproductive Medicine 632
- Cancer Research 867
Countries citing papers authored by Peter Harper
This map shows the geographic impact of Peter Harper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Harper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Harper more than expected).
Fields of papers citing papers by Peter Harper
This network shows the impact of papers produced by Peter Harper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Harper. The network helps show where Peter Harper may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Peter Harper, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 0 | |
| 2 | 2012 | 31 | |
| 3 | Evaluation of New Platinum-Based Treatment Regimens in Advanced-Stage Ovarian Cancer: A Phase III Trial of the Gynecologic Cancer InterGroupbreakdown → | 2009 | 500 |
| 4 | 2009 | 40 | |
| 5 | International Consensus Panel Recommendations for the diagnosis of bone metastases (METS) from lung cancer (LC) | 2008 | 4 |
| 6 | 2008 | 52 | |
| 7 | 2007 | 1 | |
| 8 | 2006 | 74 | |
| 9 | Gastro-oesophageal complications in patients receiving cancer therapy: the role of proton pump inhibitors. | 2002 | 11 |
| 10 | 2001 | 9 | |
| 11 | 2001 | 2 | |
| 12 | 2000 | 82 | |
| 13 | 1999 | 221 | |
| 14 | 1992 | 33 | |
| 15 | 1991 | 13 | |
| 16 | 1989 | 10 | |
| 17 | 1985 | 45 | |
| 18 | 1984 | 104 | |
| 19 | 1984 | 71 | |
| 20 | 1983 | 23 |
About Peter Harper
Peter Harper is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Reproductive Medicine, having authored 139 papers that have together received 7.7k indexed citations. Recurring topics across this work include Lung Cancer Research Studies (28 papers), Lung Cancer Treatments and Mutations (25 papers), Neuroendocrine Tumor Research Advances (18 papers), Gastric Cancer Management and Outcomes (17 papers), Colorectal Cancer Treatments and Studies (15 papers), Esophageal Cancer Research and Treatment (14 papers), Cancer Treatment and Pharmacology (14 papers) and Lung Cancer Diagnosis and Treatment (12 papers). The work is most often cited by research in Oncology (4.7k citations), Pulmonary and Respiratory Medicine (3.2k citations) and Gastroenterology (421 citations). Peter Harper has collaborated with scholars based in United Kingdom, United States and Canada. Frequent co-authors include David Cunningham, Allan B. Okey, David S. Riddick, Tamas Hickish, A. Norman, Timothy Iveson, Stephen Spiro, Juan W. Valle, M. Nicolson and Janine Mansi. Their work appears in journals such as Journal of Clinical Oncology, Cancer Chemotherapy and Pharmacology, Annals of Oncology, British Journal of Cancer and Lung Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.